|
Registration number |
VD - 15663 - 11 |
|
Composition |
Prednisolon................................................................................5 mg |
|
Dosage form |
Tablets |
|
Package |
Box x 50 blister x 20 tablet |
|
Indication |
Prednisolone is indicated when the anti-inflammatory and immunosuppressive effects are required: - Rheumatoid arthritis, systemic erysipelas, some vasculitis; temporal arteritis, periarteritis nodosa, sarcoidosis, bronchial asthma, ulcerative colitis, hemolytic anemia, granulocytopenia, and severe allergic reactions including anaphylaxis. - Cancer, like acute leukemia, lymphoma, breast cancer, and prostate cancer in the late stage. |
|
Dosage |
Medical indication Read insert paper carefully before using |
|
Specification |
DĐVN IV |
|
Use by date |
36 months from date of manufacture |
|
Storage |
Store in dry, controlled temperature below 30ºC, protect from light. |